Neuroprotection by flavonoids

Kolominsky-Rabas PL, 1998, A prospective community-based study of stroke in Germany: The Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months, Stroke, 29, 2501, 10.1161/01.STR.29.12.2501

Samsa G, 1999, Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost, Stroke, 30, 338, 10.1161/01.STR.30.2.338

Leppälä J, 1999, Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants, Stroke, 30, 2535, 10.1161/01.STR.30.12.2535

Alexi T, 2000, Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases, Progress in Neurobiology, 60, 409, 10.1016/S0301-0082(99)00032-5

Nicholls D, 1990, The release and uptake of excitatory amino acids, Trends in Pharmacological Sciences, 11, 462, 10.1016/0165-6147(90)90129-V

Nicotera P, 1999, Excitotoxins in neuronal apoptosis and necrosis, Journal of Cerebral Blood Flow and Metabolism, 19, 583, 10.1097/00004647-199906000-00001

Welch KMA, 1997

Picq M, 1989, Flavonoid modulation of protein kinase C activation, Life Sciences, 44, 1563, 10.1016/0024-3205(89)90450-5

Dugan LL, 1999, Hypoxic-ischemic brain injury and oxidative stress

Landemmer U, 2001, Oxidative stress and vascular damage in hypertension, Coronary Artery Disease, 12, 455, 10.1097/00019501-200109000-00004

Landemmer U, 2001, Oxidant stress as a marker for cardiovascular events: Ox marks the spot, Circulation, 104, 2638, 10.1161/circ.104.22.2638

Emmert D, 1999, The role of vitamin E in the prevention of heart disease, Archives of Family Medicine, 8, 537, 10.1001/archfami.8.6.537

Colqhoun D, 2002, Nutraceuticals: vitamins and other nutrients in coronary heart disease, Current Opinion in Lipidology, 12, 639, 10.1097/00041433-200112000-00007

Duthie G, 2000, Plant derived phenolic antioxidants, Current Opinion in Clinical Nutrition and Metabolic Care, 3, 457, 10.1097/00075197-200011000-00006

Riso P, 1999, Does tomato consumption effectively increase the resistance of lymphocyte DNA to oxidative damage?, American Journal of Clinical Nutrition, 69, 712, 10.1093/ajcn/69.4.712

Sung H, 2000, In vivo antioxidant effect of green tea, European Journal of Clinical Nutrition, 54, 527, 10.1038/sj.ejcn.1600994

Bastianetto S, 2002, Natural extracts as possible protective agents of brain aging, Neurobiology of Aging, 23, 891, 10.1016/S0197-4580(02)00024-6

Esposito E, 2002, A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes, Neurobiology of Aging, 23, 719, 10.1016/S0197-4580(02)00078-7

Rice Evans C, 2001, Flavonoid antioxidants, Current Medicinal Chemistry, 8, 797, 10.2174/0929867013373011

Matter WF, 1992, The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs, Biochemical and Biophysical Research Communications, 186, 624, 10.1016/0006-291X(92)90792-J

Chang WS, 1993, Inhibitory effects of flavonoids on xanthine oxidase, Anticancer Research, 13, 2165

1992

Fujiki H, 1986, Inhibition of tumor promotion by flavonoids, 429

Beretz A, 1981, Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin, Biochemical Pharmacology, 31, 3597, 10.1016/0006-2952(82)90581-0

Gryglewski RJ, 1987, On the mechanism of antithrombotic action of flavonoids, Biochemical Pharmacology, 36, 317, 10.1016/0006-2952(87)90288-7

Scambia G, 1990, Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumors and cultured cells, British Journal of Cancer, 62, 942, 10.1038/bjc.1990.414

Yoshida M, 1992, The effect of quercetin on cell cycle progression and growth of human gastric cancer cells, FEBS Letters, 260, 10, 10.1016/0014-5793(90)80053-L

Juurlink BH, 1998, Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies, Journal of Spinal Cord Medicine, 21, 309, 10.1080/10790268.1998.11719540

Agullo G, 1997, Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition, Biochemical Pharmacology, 53, 1649, 10.1016/S0006-2952(97)82453-7

Gschwendt M, 1983, Inhibition of the calcium and phospholipid dependent protein kinase activity from mouse brain cytosol by quercetin, Biochemical and Biophysical Research Communications, 117, 444, 10.1016/0006-291X(83)91220-2

Tamura M, 1994, Effects of flavonoid compounds on the activity of NADPH diaphorase prepared from the mouse brain, Japanese Journal of Pharmacology, 665, 371, 10.1254/jjp.65.371

Assemi M, 2001, Herbs affecting the central nervous system: ginkgo, kava, St. John's wort and valerian, Clinical Obstretics and Gynecology, 44, 824, 10.1097/00003081-200112000-00020

Backhauss C, 1992, Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents, European Journal of Pharmacology, 215, 265, 10.1016/0014-2999(92)90037-5

Oyama Y, 1994, Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons, Brain Research, 635, 125, 10.1016/0006-8993(94)91431-1

Lee EJ, 2002, Acute administration of Ginkgo biloba extract (Egb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats, Journal of Neuroscience Research, 68, 636, 10.1002/jnr.10251

Mashour NH, 1998, Herbal medicines for the treatment of cardiovascular disease: clinical considerations, Archives of Internal Medicine, 158, 2225, 10.1001/archinte.158.20.2225

Meseguer E, 2002, Life threatening parkinsonism induced by kava-kava, Movement Disorders, 17, 195

Shutenko Z, 1999, Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion, Biochemical Pharmacology, 57, 199, 10.1016/S0006-2952(98)00296-2

Abd-El-Gawad HM, 2001, Quercetin, coenzyme Q10 and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain, Pharmacological Research, 43, 257, 10.1006/phrs.2000.0781

Schoroeter H, 2002, MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide, Neurobiology of Aging, 23, 861, 10.1016/S0197-4580(02)00075-1

Yamakawa H, 2000, Activation of caspase-9 and -3 during H2O2-induced apoptosis of PC12 cells independent of ceramide formation, Neurological Research, 22, 556

Jiang D, 2001, Caspase 3 inhibition attenuates hydrogen peroxide-induced DNA fragmentation but not cell death in neuronal PC12 cells, Journal of Neurochemistry, 76, 1745, 10.1046/j.1471-4159.2001.00151.x

Wang R, 2002, Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells, Brain Research. Molecular Brain Research, 107, 1, 10.1016/S0169-328X(02)00402-3

Arredondo F, 2003, Cytoprotection by Achyrocline satureoides (Lam) DC and some of its flavonoids against oxidative stress, Journal of Ethnopharmacology

Dajas F, 2003, Cell culture protection and in vivo neuroprotective capacity of flavonoids, Neurotoxicity Research, 5, 377, 10.1007/BF03033172

Azuma K, 2002, Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats, Journal of Agricultural and Food Chemistry, 50, 1706, 10.1021/jf0112421

Oliveira EJ, 2002, Metabolism of quercetin and kaempferol by rat hepatocytes and the identification of flavonoid glycosides in human plasma, Xenobiotica, 32, 279, 10.1080/00498250110107886

Dajas F, 2001, Antioxidant and cholinergic neuroprotective mechanisms in experimental parkinsonism, Functional Neurology, 17, 37

Dajas-Bailador F, 1998, Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation, Brain Research, 813, 18, 10.1016/S0006-8993(98)00989-5

Costa G, 2001, Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra, Brain Research, 888, 336

Dajas F, 2002, 1241

Sydserff SG, 1995, The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat, Neurodegeneration, 4, 323, 10.1016/1055-8330(95)90022-5

Swanson RA, 1990, A semiautomated method for measuring brain infarct volume, Journal of Cerebral Blood Flow and Metabolism, 10, 290, 10.1038/jcbfm.1990.47

Margail S, 1996, Short therapeutic window for MK801 in transient focal cerebral ischemia in normotensive rats, Journal of Cerebral Blood Flow and Metabolism, 16, 107, 10.1097/00004647-199601000-00013

O'Neill M, 2001, LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia, Brain Research, 888, 138, 10.1016/S0006-8993(00)03043-2

Welton AF, 1986, Effect of flavonoids on arachidonic acid metabolism, Progress in Clinical and Biological Research, 213, 231